Onderneming Sienna Biopharmaceuticals, Inc. Other OTC
Aandelen
SNNAQ
US82622H1086
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 59 | 27-06-10 | |
Majed Kheir
COO | Chief Operating Officer | 46 | 01-01-16 |
Silvio Traversa
CTO | Chief Tech/Sci/R&D Officer | 54 | 01-12-16 |
Sean P. Andrews
IRC | Investor Relations Contact | - | - |
General Counsel | 45 | 01-10-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dennis Fenton
BRD | Director/Board Member | 72 | 01-10-16 |
Founder | 59 | 27-06-10 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 31 050 542 | 30 907 542 ( 99,54 %) | 143 000 ( 0,4605 %) | 99,54 % |
Bedrijfsgegevens
Sienna Biopharmaceuticals, Inc.
30699 Russell Ranch Road Suite 140
91362, Westlake Village
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,42% | 114 mld. | |
+11,84% | 104 mld. | |
-14,15% | 22,41 mld. | |
-1,05% | 22,28 mld. | |
-5,29% | 19,07 mld. | |
-38,29% | 18 mld. | |
-4,16% | 17,89 mld. | |
+7,99% | 14,28 mld. | |
+36,24% | 12,55 mld. |